XML 48 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity (Tables)
9 Months Ended
Sep. 30, 2017
Equity [Abstract]  
Schedule of accumulated other comprehensive income
The following tables present the components of accumulated other comprehensive income. The tables exclude MBS and GSE CRTs that are accounted for under the fair value option.
 
Three Months Ended September 30, 2017
$ in thousands
Equity method investments
 
Available-for-sale securities
 
Derivatives and hedging
 
Total
Other comprehensive income/(loss), net
 
 
 
 
 
 
 
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net

 
19,089

 

 
19,089

Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net

 
7

 

 
7

Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense

 

 
(6,438
)
 
(6,438
)
Currency translation adjustments on investment in unconsolidated venture
807

 

 

 
807

Other comprehensive income/(loss), net
807

 
19,096

 
(6,438
)
 
13,465

 
 
 
 
 
 
 
 
Balance at beginning of period
(375
)
 
201,158

 
136,608

 
337,391

Other comprehensive income/(loss), net
807

 
19,096

 
(6,438
)
 
13,465

Other comprehensive income/(loss) attributable to non-controlling interest
(10
)
 
(241
)
 
81

 
(170
)
Rebalancing of ownership percentage of non-controlling interest


 

 

 

Balance at end of period
422

 
220,013

 
130,251

 
350,686

 
Three Months Ended September 30, 2016
$ in thousands
Equity method investments
 
Available-for-sale securities
 
Derivatives and hedging
 
Total
Other comprehensive income/(loss), net
 
 
 
 
 
 
 
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net

 
32,015

 

 
32,015

Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net

 

 

 

Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense

 

 
(4,831
)
 
(4,831
)
Currency translation adjustments on investment in unconsolidated venture
(235
)
 

 

 
(235
)
Other comprehensive income/(loss), net
(235
)
 
32,015

 
(4,831
)
 
26,949

 
 
 
 
 
 
 
 
Balance at beginning of period
190

 
394,531

 
164,233

 
558,954

Other comprehensive income/(loss), net
(235
)
 
32,015

 
(4,831
)
 
26,949

Other comprehensive income/(loss) attributable to non-controlling interest
3

 
(404
)
 
61

 
(340
)
Balance at end of period
(42
)
 
426,142

 
159,463

 
585,563


 
Nine Months Ended September 30, 2017
$ in thousands
Equity method investments
 
Available-for-sale securities
 
Derivatives and hedging
 
Total
Other comprehensive income/(loss), net
 
 
 
 
 
 
 
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net

 
75,011

 

 
75,011

Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net

 
1,508

 

 
1,508

Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense

 

 
(19,105
)
 
(19,105
)
Currency translation adjustments on investment in unconsolidated venture
331

 

 

 
331

Other comprehensive income/(loss), net
331

 
76,519

 
(19,105
)
 
57,745

 
 
 
 
 
 
 
 
Balance at beginning of period
95

 
144,458

 
149,115

 
293,668

Other comprehensive income/(loss), net
331

 
76,519

 
(19,105
)
 
57,745

Other comprehensive income/(loss) attributable to non-controlling interest
(4
)
 
(965
)
 
241

 
(728
)
Rebalancing of ownership percentage of non-controlling interest

 
1

 

 
1

Balance at end of period
422

 
220,013

 
130,251

 
350,686

 
Nine Months Ended September 30, 2016
$ in thousands
Equity method investments
 
Available-for-sale securities
 
Derivatives and hedging
 
Total
Other comprehensive income/(loss), net
 
 
 
 
 
 
 
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net

 
270,591

 

 
270,591

Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net

 
(11,581
)
 

 
(11,581
)
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense

 

 
11,331

 
11,331

Currency translation adjustments on investment in unconsolidated venture
(10
)
 

 

 
(10
)
Other comprehensive income/(loss), net
(10
)
 
259,010

 
11,331

 
270,331

 
 
 
 
 
 
 
 
Balance at beginning of period
(32
)
 
170,383

 
148,273

 
318,624

Other comprehensive income/(loss), net
(10
)
 
259,010


11,331

 
270,331

Other comprehensive income/(loss) attributable to non-controlling interest

 
(3,251
)
 
(141
)
 
(3,392
)
Balance at end of period
(42
)
 
426,142

 
159,463

 
585,563

Schedule of Nonvested Restricted Stock Units Activity
The following table summarizes the activity related to restricted stock units awarded to employees of our Manager and its affiliates for the three and nine months ended September 30, 2017.
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2017
 
2017
 
Restricted Stock Units
 
Weighted Average Grant Date Fair Value (1)
 
Restricted Stock Units
 
Weighted Average Grant Date Fair Value (1)
Unvested at the beginning of the period
19,827

 
$
14.35

 
18,807

 
$
14.37

Shares granted during the period

 

 
8,115

 
15.55

Shares vested during the period

 

 
(7,095
)
 
15.78

Unvested at the end of the period
19,827

 
$
14.35

 
19,827

 
$
14.35

(1)
The grant date fair value of restricted stock awards is based on the closing market price of our common stock at the grant date.